Description
Introduction Of Igurati 25mg Tablet:
Igurati 25mg Tablet is used to treat rheumatoid arthritis. It works by improving abnormal immunological responses and suppressing the production of substances that cause redness and swelling.
Igurati 25mg Tablet can be taken with or without food. Take it regularly and do not stop taking the medicine even if you get better until that doctor tells you it is alright to stop. Drink an adequate amount of water while on treatment with this medicine, this will prevent you from getting kidney stones.
The most common side effects of this medicine include liver dysfunction, pneumonia, and upper abdominal pain. If any of these side effects persist or worsen, let yor doctor know. Your doctor may help with ways to reduce or prevent these symptoms by prescribing you an alternative medicine or by adjusting the dose.
To make sure the medicine is safe for you, let your doctor know if you have any problems with your heart, kidneys, or liver. You should also let your doctor know all the other medicines you are taking before using this medicine. If you are pregnant or breastfeeding, consult your doctor first before taking this medicine.
Uses Of Igurati 25mg Tablet
- Treatment of Rheumatoid arthritis
Benefits Of Igurati 25mg Tablet
In Treatment of Rheumatoid arthritis Igurati 25mg Tablet reduces pain, stiffness, and swelling in your joints and slows down the progression of bone and joint damage. This will help you do normal daily activities more easily and thus improve your quality of life. This medicine should be taken at the same time each day to get maximum benefits. Keep taking it even if you feel well because it is preventing future harm as well as improving your symptoms.
Mechanism Of Action Igurati 25mg Tablet
Igurati 25mg Tablet is a disease-modifying anti-rheumatic drug (DMARD). It works by improving abnormal immunological response and suppressing the production of substances that cause inflammation (redness and swelling) in rheumatoid arthritis.
Reviews
There are no reviews yet.